Mirum Pharmaceuticals, Inc. MIRM Common stock, shares authorized (in shares)
Common stock, shares authorized (in shares) at other companies
Other financials
Where this comes from
Reported directly by Mirum Pharmaceuticals, Inc. in its filing.
Tagged under the XBRL concept us-gaap:CommonStockSharesAuthorized.
The official record: Mirum Pharmaceuticals, Inc.’s 10-Q, filed May 6, 2026, on SEC EDGAR. View the filing →
Ask your AI about Mirum Pharmaceuticals, Inc.'s common stock, shares authorized (in shares).
Connect your AI assistant and compare it to peers, right in your chat.
Connect your AI
Claude
Questions, answered.
- What is Mirum Pharmaceuticals, Inc.'s common stock, shares authorized (in shares)?
- Mirum Pharmaceuticals, Inc. (MIRM) reported common stock, shares authorized (in shares) of $200M in Q1 2026.
- How has Mirum Pharmaceuticals, Inc.'s common stock, shares authorized (in shares) changed year-over-year?
- Mirum Pharmaceuticals, Inc.'s common stock, shares authorized (in shares) decreased by 0.0% year-over-year, from $200M to $200M.
- What is the long-term trend for Mirum Pharmaceuticals, Inc.'s common stock, shares authorized (in shares)?
- Over 2 years (2023 to 2025), Mirum Pharmaceuticals, Inc.'s common stock, shares authorized (in shares) has grown at a 0.0% compound annual growth rate (CAGR), from $200M to $200M.